Conditions & Recovery · Immunotherapy Updates · August 10, 2026

SYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLive

Explore the original story for the publisher’s full reporting.

Originally published by Immunotherapy Updates. We curate and add context; they did the reporting.

Related learning